Ledger.Open graph →
SEC Form D · filed May 18, 2020

QurAlis Corp

Offering
$60.0M
Sold
$33.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Luc C. Dochez · Cambridge, MADirectorAmy C. Schulman · Cambridge, MADirectorChris C. Thomajan · Cambridge, MAExecKasper C. Roet · Cambridge, MAExec · Director · PromoterDaniel C. Elbaum · Cambridge, MAExecJohannes C. Fruehauf · Cambridge, MADirectorRoel C. Bulthuis · Cambridge, MADirectorJonathan C. Fleming · Cambridge, MADirectorJonathan C. Behr · Cambridge, MADirectorLuc C. Dochez · Cambridge, MADirectorAmy C. Schulman · Cambridge, MADirectorJonathan C. Fleming · Cambridge, MADirectorChris C. Thomajan · Cambridge, MAExecKasper C. Roet · Cambridge, MAExec · Director · PromoterJonathan C. Behr · Cambridge, MADirectorDaniel C. Elbaum · Cambridge, MAExecJohannes C. Fruehauf · Cambridge, MADirectorRoel C. Bulthuis · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗